Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population
This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were rec...
Saved in:
Published in | Human vaccines & immunotherapeutics Vol. 17; no. 10; pp. 3365 - 3370 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Taylor & Francis
03.10.2021
Taylor & Francis Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease. |
---|---|
AbstractList | This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease.This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease. This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group (p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease. This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing on the perceived beliefs, knowledge, concerns, risk, and safety perception relating to the COVID-19 vaccine. A total of 423 subjects were recruited from the Pakistan Institute of Medical Sciences, Islamabad, Pakistan. A 27-item valid and reliable questionnaire was used to assess socio-demographic characteristics, acceptance, and hesitance toward COVID-19 vaccine, perceived beliefs, knowledge, perceived concerns, risk, and safety of COVID-19 vaccines and its source of information. Chi-square tests and logistic regression were used for analysis. About 53% of the participants were planning to get vaccinated and a significantly greater proportion of better educated, higher income, and healthier participants in the vaccine acceptance group ( p < .05). The odds of knowing the vaccine they should get, having the confidence in the vaccine to stop the pandemic, and understanding the way vaccines work, were greater in the vaccine acceptance group than the vaccine-hesitant group (OR: 5.4; 3.5, 2.1, 3.1, respectively). Most participants (52.3%) obtained the information regarding the COVID-19 vaccine from the print and live news media (52.3%) followed by social media (23.7%). The lack of knowledge, understanding, and perception of the risk, safety partly explains the low rate of vaccine acceptance in the Pakistani population. Strategies to raise awareness of the benefits of vaccination should target individuals in the lower socioeconomic group and those with chronic disease. |
Author | Chaudhary, Farooq Ahmad Ahmad, Basaruddin Butt, Danial Qasim Khalid, Muhammad Danial Javaid, Muhammad Mohsin Fazal, Ayesha |
Author_xml | – sequence: 1 givenname: Farooq Ahmad orcidid: 0000-0002-1748-0413 surname: Chaudhary fullname: Chaudhary, Farooq Ahmad email: chaudhary4@hotmail.com organization: Shaheed Zulfiqar Ali Bhutto Medical University – sequence: 2 givenname: Basaruddin orcidid: 0000-0003-3088-0558 surname: Ahmad fullname: Ahmad, Basaruddin organization: Universiti Sains Malaysia – sequence: 3 givenname: Muhammad Danial orcidid: 0000-0001-9788-644X surname: Khalid fullname: Khalid, Muhammad Danial organization: HITEC Institute of Medical Sciences – sequence: 4 givenname: Ayesha surname: Fazal fullname: Fazal, Ayesha organization: Shaheed Zulfiqar Ali Bhutto Medical University – sequence: 5 givenname: Muhammad Mohsin surname: Javaid fullname: Javaid, Muhammad Mohsin organization: Shaheed Zulfiqar Ali Bhutto Medical University – sequence: 6 givenname: Danial Qasim surname: Butt fullname: Butt, Danial Qasim organization: HITEC Institute of Medical Sciences |
BookMark | eNqFkV9vFCEUxYmpse3aj2Ayj77MCgx_ZmJiNKvVTZrUBzU-mBB25rJLZWAKMzX77cu4W5P6oLwAB86Pyz3n6MQHDwi9IHhJcI1fUSIY54QvKaZkSRrGJKueoLNZLzln30_-rAk_RRcp3eA8JKZMiGfotGK0Eg2nZ-jHpW7HEFNhvXET-Nb6bbG6_rZ-X5KmuNNtFqDYQbKj9u2-0L4rsgjDvIVC9yHfH3dQfNY_bcqiLYYwTE6PNvjn6KnRLsHFcV6gr5cfvqw-lVfXH9erd1dlywkZyypX3FEpm0YYXVFJBOEAVWMYFVKLGjORv2k6STDwhtamqomG7MCN0B1j1QKtD9wu6Bs1RNvruFdBW_VbCHGrdBxt60BxArlnfNPUlLKNhNp0mZyRmGMwncisNwfWMG166FrwY9TuEfTxibc7tQ13qmaVnGNYoJdHQAy3E6RR9Ta14Jz2EKakKOeYCkrk_Nbrw9U2hpQiGNXmNs-dy2TrFMFqjls9xK3muNUx7uzmf7kfivyf7-3BlyMPsde_QnSdGvXehWhijtUmVf0bcQ8GyMCS |
CitedBy_id | crossref_primary_10_3390_vaccines11061052 crossref_primary_10_1108_IJHG_05_2024_0049 crossref_primary_10_1371_journal_pgph_0003564 crossref_primary_10_2147_PPA_S376103 crossref_primary_10_1155_2022_2313367 crossref_primary_10_1080_13549839_2022_2155937 crossref_primary_10_1111_ijn_13144 crossref_primary_10_1016_j_soh_2023_100048 crossref_primary_10_1108_JPMH_02_2023_0016 crossref_primary_10_1177_20552076231211670 crossref_primary_10_1089_hs_2024_0049 crossref_primary_10_1080_21645515_2021_2013080 crossref_primary_10_1080_21645515_2023_2180969 crossref_primary_10_4103_jfmpc_jfmpc_1255_21 crossref_primary_10_2139_ssrn_4139623 crossref_primary_10_1080_21645515_2024_2369358 crossref_primary_10_7717_peerj_cs_1111 crossref_primary_10_3389_fpubh_2022_1033473 crossref_primary_10_1155_2021_8963168 crossref_primary_10_3390_vaccines10071095 crossref_primary_10_1371_journal_pone_0286794 crossref_primary_10_1016_j_vaccine_2024_126168 crossref_primary_10_1136_bmjopen_2022_064096 crossref_primary_10_3390_vaccines10111777 crossref_primary_10_55908_sdgs_v11i10_788 crossref_primary_10_1007_s40609_023_00268_9 crossref_primary_10_1080_21645515_2023_2228164 crossref_primary_10_1002_iid3_70076 crossref_primary_10_1080_21645515_2022_2068930 crossref_primary_10_2147_RMHP_S370125 crossref_primary_10_7759_cureus_19106 crossref_primary_10_1080_21645515_2021_1968215 crossref_primary_10_34172_hpp_2023_03 crossref_primary_10_7759_cureus_49576 crossref_primary_10_3390_ijerph191811531 crossref_primary_10_1080_21645515_2022_2054261 crossref_primary_10_3389_fpubh_2024_1382849 crossref_primary_10_3390_vaccines10101736 crossref_primary_10_1186_s12877_023_04518_5 crossref_primary_10_1371_journal_pgph_0002652 crossref_primary_10_1080_21645515_2021_2010426 crossref_primary_10_1186_s12982_024_00236_4 crossref_primary_10_1016_j_pedn_2022_01_015 crossref_primary_10_1080_13648470_2024_2386887 crossref_primary_10_3390_vaccines10010110 crossref_primary_10_3346_jkms_2023_38_e326 crossref_primary_10_1038_s41562_022_01431_6 crossref_primary_10_3389_fmed_2021_783982 crossref_primary_10_3389_fpubh_2022_841842 crossref_primary_10_1186_s13690_022_00904_4 crossref_primary_10_1080_01436597_2021_1995713 crossref_primary_10_3390_ijerph19031305 crossref_primary_10_1007_s44196_022_00069_6 crossref_primary_10_1007_s10389_022_01728_w crossref_primary_10_1136_bmjopen_2023_075297 crossref_primary_10_26900_hsq_2113 crossref_primary_10_3390_ijerph191912892 crossref_primary_10_1007_s12144_022_03622_w crossref_primary_10_3389_fpubh_2022_1100130 crossref_primary_10_1371_journal_pone_0290412 crossref_primary_10_1371_journal_pone_0270023 crossref_primary_10_3389_fendo_2023_1172089 crossref_primary_10_3390_vaccines10071076 crossref_primary_10_36740_WLek202209114 crossref_primary_10_37762_jgmds_10_3_460 crossref_primary_10_1016_j_puhe_2023_01_014 crossref_primary_10_3390_vaccines9121384 crossref_primary_10_3390_ijerph20237093 crossref_primary_10_1080_21645515_2022_2050121 crossref_primary_10_1186_s41182_022_00453_0 |
Cites_doi | 10.1038/s41591-020-1124-9 10.1377/hlthaff.24.3.611 10.3390/ijerph17217818 10.1016/j.vaccine.2015.04.036 10.3390/vaccines8010002 10.4161/hv.24657 10.1016/S0140-6736(21)00085-4 10.1016/j.ijid.2020.03.017 10.1016/j.ijsu.2020.04.018 10.1016/j.ijid.2020.12.029 10.1093/tbm/ibaa090 10.1007/s10654-021-00728-6 10.3389/fpubh.2020.00381 10.3390/vaccines9010042 10.1186/1471-2458-13-511 10.1371/journal.pone.0248892 10.1186/s12992-016-0195-3 10.1038/s41467-020-20226-9 10.3389/fpsyg.2020.577684 10.4269/ajtmh.20-0654 10.1186/s41256-021-00188-1 10.1016/j.vaccine.2015.04.035 10.3390/vaccines8030482 10.1038/s41418-020-00720-9 10.22541/au.161519250.03425961/v1 10.1002/1348-9585.12168 10.1007/s10198-020-01208-6 10.3390/vaccines8040582 |
ContentType | Journal Article |
Copyright | 2021 Taylor & Francis Group, LLC 2021 2021 Taylor & Francis Group, LLC 2021 Taylor & Francis |
Copyright_xml | – notice: 2021 Taylor & Francis Group, LLC 2021 – notice: 2021 Taylor & Francis Group, LLC 2021 Taylor & Francis |
DBID | AAYXX CITATION 7X8 5PM DOA |
DOI | 10.1080/21645515.2021.1944743 |
DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | F. A. CHAUDHARY ET AL |
EISSN | 2164-554X |
EndPage | 3370 |
ExternalDocumentID | oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6 PMC8437474 10_1080_21645515_2021_1944743 1944743 |
Genre | Research Article |
GrantInformation_xml | – fundername: did not receive |
GroupedDBID | --- 00X 0YH 30N 4.4 53G AALUX ABEIZ ABUPF ACENM ACGFS ADBBV ADCVX AECIN AENEX AEXWM AGYJP AIJEM ALMA_UNASSIGNED_HOLDINGS ALQZU AOIJS ARJSQ BABNJ BAWUL BLEHA BOHLJ CCCUG DGEBU DIK EBS H13 HYE IPNFZ KYCEM LJTGL M4Z O9- RIG RPM TDBHL TFL TFW TTHFI AAYXX CITATION 7X8 5PM GROUPED_DOAJ |
ID | FETCH-LOGICAL-c511t-3554d277996fa3271615ee39f4267a68046021fd710e5928f381aed27096ad443 |
IEDL.DBID | DOA |
ISSN | 2164-5515 2164-554X |
IngestDate | Wed Aug 27 01:30:15 EDT 2025 Thu Aug 21 14:09:06 EDT 2025 Fri Jul 11 00:48:14 EDT 2025 Tue Jul 01 02:46:14 EDT 2025 Thu Apr 24 22:55:09 EDT 2025 Wed Dec 25 09:06:36 EST 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c511t-3554d277996fa3271615ee39f4267a68046021fd710e5928f381aed27096ad443 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-1748-0413 0000-0001-9788-644X 0000-0003-3088-0558 |
OpenAccessLink | https://doaj.org/article/51e2025b98224b7e8fd1fd8f3050efd6 |
PMID | 34236952 |
PQID | 2550262176 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | informaworld_taylorfrancis_310_1080_21645515_2021_1944743 doaj_primary_oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6 crossref_citationtrail_10_1080_21645515_2021_1944743 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8437474 crossref_primary_10_1080_21645515_2021_1944743 proquest_miscellaneous_2550262176 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-10-03 |
PublicationDateYYYYMMDD | 2021-10-03 |
PublicationDate_xml | – month: 10 year: 2021 text: 2021-10-03 day: 03 |
PublicationDecade | 2020 |
PublicationTitle | Human vaccines & immunotherapeutics |
PublicationYear | 2021 |
Publisher | Taylor & Francis Taylor & Francis Group |
Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
References | e_1_3_2_27_1 e_1_3_2_28_1 e_1_3_2_29_1 e_1_3_2_20_1 e_1_3_2_22_1 e_1_3_2_23_1 e_1_3_2_24_1 e_1_3_2_25_1 e_1_3_2_26_1 Funk C (e_1_3_2_15_1) 2020 Volkman JE (e_1_3_2_21_1) 2020 e_1_3_2_16_1 e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_18_1 e_1_3_2_7_1 Felter C (e_1_3_2_8_1) 2021 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_31_1 e_1_3_2_30_1 e_1_3_2_10_1 e_1_3_2_33_1 e_1_3_2_11_1 e_1_3_2_32_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_5_1 e_1_3_2_13_1 e_1_3_2_34_1 e_1_3_2_4_1 e_1_3_2_14_1 e_1_3_2_3_1 |
References_xml | – ident: e_1_3_2_24_1 doi: 10.1038/s41591-020-1124-9 – ident: e_1_3_2_32_1 doi: 10.1377/hlthaff.24.3.611 – ident: e_1_3_2_9_1 doi: 10.3390/ijerph17217818 – ident: e_1_3_2_11_1 doi: 10.1016/j.vaccine.2015.04.036 – ident: e_1_3_2_16_1 doi: 10.3390/vaccines8010002 – ident: e_1_3_2_13_1 doi: 10.4161/hv.24657 – ident: e_1_3_2_7_1 doi: 10.1016/S0140-6736(21)00085-4 – volume-title: Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases year: 2020 ident: e_1_3_2_15_1 – ident: e_1_3_2_31_1 doi: 10.1016/j.ijid.2020.03.017 – ident: e_1_3_2_5_1 doi: 10.1016/j.ijsu.2020.04.018 – ident: e_1_3_2_29_1 doi: 10.1016/j.ijid.2020.12.029 – ident: e_1_3_2_34_1 doi: 10.1093/tbm/ibaa090 – ident: e_1_3_2_12_1 doi: 10.1007/s10654-021-00728-6 – ident: e_1_3_2_25_1 doi: 10.3389/fpubh.2020.00381 – ident: e_1_3_2_2_1 – ident: e_1_3_2_28_1 doi: 10.3390/vaccines9010042 – ident: e_1_3_2_33_1 doi: 10.1186/1471-2458-13-511 – ident: e_1_3_2_18_1 – ident: e_1_3_2_30_1 doi: 10.1371/journal.pone.0248892 – ident: e_1_3_2_17_1 doi: 10.1186/s12992-016-0195-3 – ident: e_1_3_2_20_1 doi: 10.1038/s41467-020-20226-9 – ident: e_1_3_2_3_1 doi: 10.3389/fpsyg.2020.577684 – ident: e_1_3_2_10_1 doi: 10.4269/ajtmh.20-0654 – ident: e_1_3_2_22_1 doi: 10.1186/s41256-021-00188-1 – start-page: 1 year: 2020 ident: e_1_3_2_21_1 article-title: Information source’s influence on vaccine perceptions: an exploration into perceptions of knowledge, risk and safety publication-title: J Commun Healthc – ident: e_1_3_2_14_1 doi: 10.1016/j.vaccine.2015.04.035 – ident: e_1_3_2_26_1 doi: 10.3390/vaccines8030482 – ident: e_1_3_2_6_1 doi: 10.1038/s41418-020-00720-9 – ident: e_1_3_2_19_1 doi: 10.22541/au.161519250.03425961/v1 – ident: e_1_3_2_4_1 doi: 10.1002/1348-9585.12168 – ident: e_1_3_2_27_1 doi: 10.1007/s10198-020-01208-6 – year: 2021 ident: e_1_3_2_8_1 article-title: What to know about the global COVID-19 vaccine rollout so far publication-title: Council Foreign Relat – ident: e_1_3_2_23_1 doi: 10.3390/vaccines8040582 |
SSID | ssj0000702466 |
Score | 2.5186522 |
Snippet | This study examined the factors associated with acceptance of the COVID-19 vaccine compared to hesitance in the Pakistani population and specifically focusing... |
SourceID | doaj pubmedcentral proquest crossref informaworld |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 3365 |
SubjectTerms | COVID-19 vaccine Research Paper vaccination misinformation vaccine acceptance vaccine hesitancy |
Title | Factors influencing COVID-19 vaccine hesitancy and acceptance among the Pakistani population |
URI | https://www.tandfonline.com/doi/abs/10.1080/21645515.2021.1944743 https://www.proquest.com/docview/2550262176 https://pubmed.ncbi.nlm.nih.gov/PMC8437474 https://doaj.org/article/51e2025b98224b7e8fd1fd8f3050efd6 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PT9swFLYG0iQuCDYQHQN50q6miX_E7pHBKjZp7AKoByTLqV9EJZRWLCDx3_Oek1YNl152a9y4cvxe8r6vdr6Pse-mygMyCRCAH4QGUwgXXSbK6KwtwlSVht53_nNdXN3q3xMzWbP6oj1hrTxwO3FDkwPyc1OSzpwuLbgq5lV0FeZpBlVMYttY89bIVHoGW6w9aaFSIh8QCAvM8vUdlw2pjZqQHsr8DGm8tlr1ClPS73-nXtrDoP0dlGslabzHdjssyc_ba9hnH6D-xD627pKvn9n9uPXS4bPOiASrFL_4e_frUuQj_hKmtKbOH8gYgB6xPNSRYyMs6BB4siHiiA95hzLrGV-s7L4O2O34583FlejMFMQUMVUjCFdEaS3ymyooaQnpAahRhSXahsLRAqnEmUXEAWYkcYJdHgB7IMcJUWt1yLbreQ1HjOcRO0mjTBakDlksscSboACCKqKLcsD0cib9tFMaJ8OLR593gqTLAHgKgO8CMGBnq26LVmpjU4cfFKbVyaSUnRowf3yXP35T_gzYaD3Ivkl_lFStq4lXGwbwbZkRHu9KWmoJNcyf_3kkakhuke7h79teqvRG2_-mnj0kfW-nFZI8_eV_XN4x26ERp-2H6ivbbp6e4QRhVFOesi2VXZ-m--YN1ugT2w |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgEYILb0R5GomrS-JHnBxhoerCbrnsoj0gWU48ZitQWi0pEvx6ZvKompXQHvaWRyey3bH9ffb4G8bemJh6ZBIgAC-EBpOJPOSJKENubeYrVRo673y0yOYn-tOpOd05C0NhlcShYycU0Y7V1LlpMXoIiXsrEePjTG-Q3sl0ijRc4zx4nd0wRWbJ11Wy2K6zoEvLbsuSrASZDQd5_vel0RTVKvlf0DEdodFxLOXO5DS7y6qhWl1Myo_ppimn1d8Lio9Xq_c9dqfHrvxd52z32TWoH7CbXTbLPw_Zt1mXu4cv-8QnOCvy_S9fDz6ItOC_fUV7-PyMEhHQkM6xHBwfwppugbdpjzjiUd6j2nrJ19v0Yo_Yyezj8f5c9MkbRIUYrhGEY4K0FvlU9EpaQpYAqogICazPctqQlWkMiHDAFDKPCB08oAVyKh-0Vo_ZXr2q4QnjaUAjaZRJvNQ-CSVCCuMVgFdZyIOcMD38X67qlc0pwcZPl_YCqEPDOWo41zfchE23ZutO2uMyg_fkDNsfkzJ3-2B1_t31Hd2ZFNDGlKSLqEsLeQxYS6xeYhKIIZuwYteVXNMuzMQui4pTlxTg9eB3DkcB2trxNaw2vxwSQyTTSC_x-3bkkKPSjt_Uy7NWTzzXCkmlfnqFkr1it-bHR4fu8GDx-Rm7Ta_aiEf1nO015xt4gcitKV-2XfMfha4zNA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagFagXKI-qS3kYiauXxI8ke-yDVctj4UARByTLicd0Bcqu2ixS-fXMJM6qqYR66G032Yls79jzffH4G8bemJA6ZBIgAD8IDSYThS8SUfoizzNXqdLQeedPs-z4VL__bvpswouYVkkcOnRCEe1aTZN76UOfEfdWIsTHQG-Q3cl0jCxcYxi8yzYzOmhJpziS2fo1C3q07HYsyUqQWX-O539PGkSoVsj_mozpAIwOUymvxKbpQ1b2vepSUn6NV005rv5eE3y8Vbe32YOIXPl-52qP2B2oH7N7XS3Lyyfsx7Sr3MPnsewJxkR--PnbyZFIJ_yPq2gHn59RGQJa0Dk2g-NFWNJX4G3RI45olEdMW8_5cl1c7Ck7nb77engsYukGUSGCawShGC_zHNlUcErmhCsB1CQgIMhdVtB2rEyDR3wDZiKLgMDBAVogo3Jea7XDNupFDbuMpx6NpFEmcVK7xJcIKIxTAE5lvvByxHT_d9kq6ppTeY3fNo3yp_3AWRo4GwduxMZrs2Un7HGTwQH5wvrHpMvdXlic_7RxmluTAtqYklQRdZlDETz2EruXmASCz0ZsctWTbNO-lgldDRWrbmjA697tLK4BtLHjalisLizSQqTSSC7x-fnAHwetHd6p52etmnihFVJK_ewWLXvF7n85mtqPJ7MPe2yL7rTpjuo522jOV_ACYVtTvmwn5j-HkTHY |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Factors+influencing+COVID-19+vaccine+hesitancy+and+acceptance+among+the+Pakistani+population&rft.jtitle=Human+vaccines+%26+immunotherapeutics&rft.au=Farooq+Ahmad+Chaudhary&rft.au=Basaruddin+Ahmad&rft.au=Muhammad+Danial+Khalid&rft.au=Ayesha+Fazal&rft.date=2021-10-03&rft.pub=Taylor+%26+Francis+Group&rft.issn=2164-5515&rft.eissn=2164-554X&rft.volume=17&rft.issue=10&rft.spage=3365&rft.epage=3370&rft_id=info:doi/10.1080%2F21645515.2021.1944743&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_51e2025b98224b7e8fd1fd8f3050efd6 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2164-5515&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2164-5515&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2164-5515&client=summon |